Oragenics, Inc. (OGEN)
0.201
-0.15
(-42.59%)
USD |
NYAM |
Nov 13, 16:00
0.2061
+0.01
(+2.54%)
After-Hours: 19:59
Oragenics Price to Book Value : 0.8301 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 0.8301 |
| November 12, 2026 | 1.446 |
| November 11, 2026 | 1.409 |
| November 10, 2026 | 1.417 |
| November 09, 2026 | 1.465 |
| November 06, 2026 | 1.442 |
| November 05, 2026 | 1.441 |
| November 04, 2026 | 1.536 |
| November 03, 2026 | 1.528 |
| November 02, 2026 | 1.529 |
| October 30, 2026 | 1.545 |
| October 29, 2026 | 1.545 |
| October 28, 2026 | 1.569 |
| October 27, 2026 | 1.512 |
| October 26, 2026 | 1.646 |
| October 23, 2026 | 1.722 |
| October 22, 2026 | 1.674 |
| October 21, 2026 | 1.705 |
| October 20, 2026 | 1.792 |
| October 19, 2026 | 1.743 |
| October 16, 2026 | 1.796 |
| October 15, 2026 | 1.801 |
| October 14, 2026 | 1.805 |
| October 13, 2026 | 1.846 |
| October 12, 2026 | 1.849 |
| Date | Value |
|---|---|
| October 09, 2026 | 1.883 |
| October 08, 2026 | 1.912 |
| October 07, 2026 | 2.065 |
| October 06, 2026 | 2.003 |
| October 05, 2026 | 2.008 |
| October 02, 2026 | 2.014 |
| October 01, 2026 | 1.982 |
| September 30, 2026 | 2.031 |
| September 29, 2026 | 0.59 |
| September 28, 2026 | 0.5797 |
| September 25, 2026 | 0.5996 |
| September 24, 2026 | 0.6183 |
| September 23, 2026 | 0.5974 |
| September 22, 2026 | 0.6392 |
| September 21, 2026 | 0.638 |
| September 18, 2026 | 0.586 |
| September 17, 2026 | 0.638 |
| September 16, 2026 | 0.6146 |
| September 15, 2026 | 0.5994 |
| September 14, 2026 | 0.6134 |
| September 11, 2026 | 0.5876 |
| September 10, 2026 | 0.6187 |
| September 09, 2026 | 0.6331 |
| September 08, 2026 | 0.642 |
| September 04, 2026 | 0.6269 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Candel Therapeutics, Inc. | 3.696 |
| ACADIA Pharmaceuticals, Inc. | 2.335 |
| Alnylam Pharmaceuticals, Inc. | 6.131 |
| Anika Therapeutics, Inc. | 1.305 |
| Savara, Inc. | 8.843 |
Price to Book Value Related Metrics
| Price | 0.201 |
| Earnings Yield | -1.09K% |
| Market Cap | 0.9069M |